Jupyter and Galaxy: Easing entry barriers into complex data analyses for biomedical researchers

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

item.page.other

item.page.references

Abstract

What does it take to convert a heap of sequencing data into a publishable result? First, common tools are employed to reduce primary data (sequencing reads) to a form suitable for further analyses (i.e., the list of variable sites). The subsequent exploratory stage is much more ad hoc and requires the development of custom scripts and pipelines, making it problematic for biomedical researchers. Here, we describe a hybrid platform combining common analysis pathways with the ability to explore data interactively. It aims to fully encompass and simplify the "raw data-to-publication" pathway and make it reproducible.

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

PLoS Comput Biol. 2017 May; 13(5): e1005425

Keywords

Biomedical Research/methods, Biomedical Research/organization & administration, Computational Biology, High-Throughput Nucleotide Sequencing, Humans, Research Personnel, Software

item.page.dc.rights

item.page.dc.rights.url